top of page

Speaker Profile:

Rachel Hutman headshot
Rachel Hutman

CEO & Founder

Ford Hutman Media

Rachel has worked on some of the world's biggest therapies and medical technologies of all time, including the first RNAi therapy (Alnylam’s ONPATTRO), the first therapy for DMD (Sarepta’s EXONDYS 51), the first technology in the world to personalize insulin 24 hrs. a day (Medtronic’s MiniMed 670G), IBM's AI launch into healthcare (Watson Health) and Google's sister life science company (Verily). 


Bridging the Gap: The Benefits of Scale in the Transition to Value-Based Care
bottom of page